Business Context and Reporting Period
This Form 10-Q covers The Procter & Gamble Company (P&G) for the quarterly period ended September 30, 2004. P&G markets approximately 300 consumer products in over 160 countries across three global business units: Beauty Care; Health, Baby and Family Care; and Household Care. The company operates in over 80 countries through its Market Development Organization.
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 | Change |
|---|---|---|---|
| Net Sales | $13,744 million | $12,195 million | +13% |
| Net Earnings | $2,001 million | $1,761 million | +14% |
| Diluted EPS | $0.73 | $0.63 | +16% |
| Operating Cash Flow | $1,918 million | $1,606 million | +19% |
| Free Cash Flow | $1,505 million | $1,242 million | +21% |
| Free Cash Flow Productivity | 75% | 71% | +4 pts |
| Total Debt (Short + Long Term) | $21,432 million | $19,991 million* | Increased |
| Cash and Equivalents | $6,262 million | $4,049 million | +55% |
*Prior year debt calculated from Q1 2003 balance sheet data not fully detailed in this excerpt, but current period debt increased by $437 million during the quarter.
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 13% (10% excluding foreign exchange). Organic sales grew 6%. Unit volume increased 12%, driven by developing markets (20%+ growth) and double-digit growth in Beauty Care and Fabric & Home Care.
- Profitability: Net earnings rose 14% to $2.0 billion. Operating margin decreased 80 basis points to 20.9% due to higher SG&A expenses (up 90 bps) primarily from the Wella acquisition and marketing investments.
- Divestiture Impact: The sale of the juice business in August 2004 contributed a gain to non-operating income and $0.02 to diluted EPS.
- Acquisition Impact: The Wella AG acquisition (completed Sept 2003) contributed two additional months of results, increasing goodwill and SG&A expenses.
- Currency: Foreign exchange had a positive 3% impact on sales, driven by the Euro, British pound, and Japanese yen.
Guidance, Outlook, and Risks
Outlook and Commentary: Management maintains a long-term target of 90% free cash flow productivity, though Q1 results were 75%. Capital expenditures were 3% of net sales, below the 4% long-term target. The company expects higher commodity prices to continue through the fiscal year, negatively impacting gross margins.
Key Risks and Contingencies:
- Commodity Costs: Rising raw material prices are expected to pressure margins.
- Competition: High levels of competitive activity, particularly from hard discounters in Europe, necessitated price reductions in some categories.
- Integration: Successful execution and integration of key acquisitions, specifically Wella.
- Regulatory/Legal: Exposure to product liability, patent, and intellectual property matters.
- Geopolitical: Global political and economic uncertainty, including potential disruptions from terrorist activities.
Investor Verification Checklist
- Wella Integration: Verify the timeline for Wella's margin improvement and the full impact of its higher SG&A ratio on the Beauty Care segment.
- Commodity Hedging: Assess the company's ability to pass on higher raw material costs to consumers without losing volume, given the stated expectation of continued price increases.
- Free Cash Flow Productivity: Monitor the trajectory to reach the 90% annual target, as Q1 productivity (75%) was below target.
- Developing Markets: Confirm that volume growth in developing markets continues to offset lower average unit sales prices and margin compression.
- Debt Management: Review the company's strategy for managing the increased gross debt position ($437 million increase in Q1) and the reduction of short-term commercial paper balances.